J&J dumps Aegis Group's Carat

Share this article:
Johnson & Johnson dumped Aegis Group's Carat as it began a root-and-branch review of its media planning and buying assignments, according to Advertising Age. Carat had handled media on a number of the Pfizer OTC brands being acquired by J&J. Those brands will be divided up among roster agencies that survive the review, Ad Age reported.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.